IMAGI Health’s Post

🌱 Two weeks ago, at EIT Health #InnoStarsConnect in Budapest, on behalf of mama health, I announced for the first time our revolutionary feature: "ASK OUR AI" This enables our clients to ask any question about the patient journey and get detailed answers based on real-world evidence, in seconds. A huge thank you to the meeting convenors Sarah Haddadin Jorge Pimenta Maria Burpee and all for organizing such a forward-thinking event and the team at Chiesi Group: Marta Lombardini Vera Codazzi Carmelida Capaldi Fabrizio Conicella who selected us for the InnoStars program. And a big thank you to all our fellow startups, I’m grateful to have been part of this inspiring experience 🌱

Hey there! I’m Cynthia, and welcome to Startup Countdown. Today we'll be counting down three AI startups in Healthcare. Number three, Syntrillo. Syntrillo is re-imagining neurological care. Through a combination of digital health and AI, they are making expert-level, preventative stroke care accessible to the millions of people at-risk of stroke.  They’ve raised an undisclosed amount in seed funding. Syntrillo is led by Brett Mankey Number two, Bionic Health. Live your best life longer. Get personalized preventative medicine delivered by doctors using the latest in modern, longevity medicine. They’ve raised $3 million in seed funding. Bionic Health is led by Robbie Allen And number one, Samay. Samay is on a quest to stop the progression of and ultimately prevent respiratory diseases by empowering patients, caregivers/families and clinicians with high quality and actionable health information at home. They’ve raised $5.2 million. Samay is led by Maria Artunduaga, MD, MPH, MTM That's it for this week's Startup Countdown. Tune in next week, and don’t forget to follow, like, and share.

🚀 Applications for Cohort V of the Innovators Club, our FREE 10-week network accelerator programme, are open NOW! Since launching in 2020, we've run one Innovators Club programme each year, welcoming a total of 20 life science start-ups across four cohorts. We're incredibly proud of the outstanding progress our Innovators Club alumni have gone on to achieve with just some of many highlights including: ⚡ Phycobloom and Phase Biolabs being selected to join the Breakthrough Energy Fellowship, with backing from Bill Gates 🤝 CC Bio being acquired by Precisio Biotix Therapeutics 🐶 Zonova being selected to join Zoetis' Veterinary Health Innovation Engine 🏆 Countless national and international awards and recognitions 💸 One stat we love to share is that our alumni have collectively raised over £62m in equity funding once they completed their respective programmes. A huge testament to the meaningful innovations each of our companies are developing from revolutionising human health to solving the climate crisis and everything in between. 👩🔬 We're also very proud of the fact that 45% of our alumni companies are women-led with at least one female founder or co-founder. 🔎 We're now on the lookout for the next cohort of stellar early-stage life science innovators. Could this be you? ⏰ Applications for Cohort V close on August 2nd! Find out more about the programme and how to apply here 👉 https://lnkd.in/efakJZV Innovators Club Cohort V, powered by Gold sponsor Marks & Clerk. If you're interesting in supporting Cohort V as a sponsor, drop Matthew McCann a message! #InnovatorsClub #innovation #accelerator #lifesciences

We are excited to share that Abac Nest has invested in Punto Health, the leading platform for the management of Alzheimer's and other dementias! 🧠 When we met Anna Muñoz Farré and Jack Eckersley, we were moved by their vision to improve the quality of life of the c.30m people who experience dementia in Europe and North America. These chronic conditions take a huge toll on the well-being of patients, their families, and the healthcare system, which is why early detection and continued management are key to delaying its evolution. 🔬 In this context, Punto Health's AI-based voice biomarker offers a unique opportunity to continuously monitor the evolution of patients while offering 24/7 tailored support to help families navigate the disease. Punto's technology also empowers healthcare providers to deliver better care at scale unlocking significant cost savings and increasing their efficiency in personalizing treatments. 💻 Anna Muñoz Farré and Jack Eckersley are leveraging their unique experience in biomedicine and technology at Massachusetts Institute of Technology, University of Cambridge, Universitat Politècnica de Catalunya and BenevolentAI to build a platform that connects patients, families, and caregivers. As early-stage VC investors, at Abac Nest we are thrilled to join Punto Health and share this journey with HEARTFELT_, Fondo Bolsa Social , Bruce Walker (scout at Ada Ventures), Gail Armstrong from Lavender Ventures, and a Sequoia Capital scout 🚀 Joan Pina Olle Marta Campillo Anna Pellicer Tristán Conde Maria Mas Ruiz Ace Alzheimer Center Barcelona Link EU-Startups by Stefano De Marzo: https://lnkd.in/dRFXQjn5 Link The New Barcelona Post: https://lnkd.in/dnwqKBSv

Last week's digital health news 🚀👇 💰 From the funds 🇱🇺 David Buller and Laurent van Lerberghe unveiled KELES, a €250 million fund to invest in digital health. 🇨🇿 Tensor Ventures launched a €50 million fund to invest in quantum, biotech, and climate technologies. 💸 From the startups 🇬🇧 Basecamp Research raised $60 million to build a "GPT for biology." (Singular, Broad Institute of MIT and Harvard) 🇺🇸 VieCure secured $45 million to accelerate the adoption of the first AI-based community oncology care platform. (Northpond Ventures) 🇫🇷 Qantev raised €30 million for its AI-powered platform assisting health insurers in decision-making. (Blossom Capital, Elaia, Omnes Capital, RAISE) 🇺🇸 MiLaboratories raised $10 million for its platform aimed at accelerating genomic research (Kfund, Acrobator Ventures, EGB Capital, Courtyard Ventures, Somersault Ventures, Speedinvest, Ten13) 🇺🇸 Rezilient Health announced a $10 million funding round to provide hybrid primary care. (Govo Venture Partners) 🇫🇷 Generare raised €5 million to discover new drugs using microbial DNA. (Teampact.ventures, Galion.exe, VIVES Partners) 🇺🇸 LEVY Health secured $4.5 million to help women identify fertility issues earlier. (XYZ Venture Capital, Atlantic Labs, Possible Ventures) 🧐 The Curious Mind 🎖️ Demis Hassabis and John Jumper, CEO and director of Google DeepMind, were awarded the Nobel Prize in Chemistry for developing AlphaFold, an AI system that predicts the 3D structure of proteins. 🇨🇦 Alan became the first new health insurance company in Canada in nearly 70 years. 🤖 Vivid Mind enables doctors to detect dementia by analyzing patients' voice patterns. Find all the details here (in French 🇫🇷): https://lnkd.in/etHCDBnA

BrainScan.AI, the winner of this year's LSBC pitch competition, has secured its place in the HICEE Support Programme, bringing the total number of participating start-ups to 2️⃣ 5️⃣ This Polish venture, currently at an advanced stage of development, is revolutionising brain pathology diagnostics with cutting-edge #AI technology. It was recently awarded the Best AI-Driven Solution title at the European Awards in Medicine 2024. BrainScan’s journey with EIT Health began in 2019, having participated in the Headstart programme, followed by Catapult in 2020. With BrainScan on board, the HICEE Support Programme is set to empower these innovative start-ups, helping them become investment-ready and make a significant impact on the European market. But the journey doesn’t end here - eight ventures will advance to the next stage and gain access to EIT Health Accelerator’s comprehensive support services. 🚀 #HICEE #CEEStartups #HealthcareInnovation

We’re thrilled to see URIMON, CC Diagnostics, and NimBio among the innovative start-ups advancing to the next stage of the EIT Health Catapult. 🎉 Congratulations to these trailblazers from our region! 🎉 URIMON / You2Yourself, Bram De Moor – advancing proactive healthcare with a urine test for early detection of serious diseases, like cancer and cardiovascular conditions. CC Diagnostics, Ilinka Stanciu – enhancing cervical cancer screening with a DNA-damage test that is both faster and more accurate, with 97% sensitivity and the option for self-sampling. NimBio, Tal Atarot – creating the world’s first non-invasive inflammometer to catch early signs of inflammatory diseases, offering a new approach for the 20% of people in Western populations affected by these conditions. These innovators join 27 other ground-breaking start-ups that will showcase their transformative healthtech and life sciences solutions to investors, healthcare professionals, and industry leaders from across Europe. We congratulate all the semi-finalists and look forward to seeing these passionate innovators push boundaries and inspire change in healthcare. For the full list of selected start-ups, check here:  https://lnkd.in/eudWYHEj #HealthcateInnovation #LifeSciences #HealthTech

🎉 We are officially part of the 🇪🇺 EIT Health Catapult program, in partnership with 🇩🇪 bioRN Life Science Cluster Rhine-Neckar, 🇩🇪 Medical Valley EMN e. V., and 🇫🇷 Capdigital. We will benefit from targeted training days, webinar series, and critical investor exposure. 🌐💡In 2024, Healthtech has emerged as the 5th largest venture capital investment category, trailing only behind heavyweights like Fintech, Energy, Biotech and Pharma. This growth is driven by the rising demand for innovative healthcare solutions, advances in technologies like AI and genomics, and the sector’s potential for long-term growth and returns. Notably, FemTech has experienced steady growth over the past decade. Furthermore, Barcelona, where we are based, ranks among the top 10 cities for investment in EMEA! Our mission in this program? To connect with the right people at the right time to secure the funding needed to bring The Blue Box to market. We're driven to transform healthcare, and with the right support, we're confident we can make a global impact. 🌍🔬

Breaking bones is unfortunately a common part of life; in fact doctors treat about 6.8 million fractures each year in the United States, and the average person can expect to sustain two fractures over their lifetime. In the latest episode of the #MedtechImpactPodcast, Kyle Kruse 🚀and I are joined by Brian Hess, CEO and Founder of RevBio, Inc., who is helping to transform bone repair with their innovative adhesive. Not only is this solution boosting how bones can rapidly fuse back together through its biomimicry properties, this is a product that stimulates bone growth and leaves no artifact in the body. From raising nearly $20 million in non-dilutive funding, it’s clear that this technology has huge potential with multiple indications available to be applied to. Brian lays out a clear strategic path to market that includes the opportunity to leverage early animal studies with veterinarians also seeing significant value from this exciting technology in the near term. Throughout this discussion, Brian displays all the attributes of a great leader. With a top co-founder coupled alongside in D. Grayson Allen, Brian shares how they have developed a winning culture, and a team that thrives on the opportunities they are given to both develop personally and help take this product to market. As a UMassM2D2 resident, RevBio is able to access a number of resources and an incredible pipeline of young talented interns who have grown with the company and stepped up into more senior roles. This is a startup story that is packed full of the hallmarks for building a successful innovative medical solution, and one that is sure to leave you informed and inspired. Look out for Brian if you're heading to LSI next week and would like to learn more about their exciting innovation. And if you're interested in joining RevBio at one of the world's leading medtech incubators here at M2D2, be sure to get in touch! https://lnkd.in/drZhga2T University of Massachusetts Lowell, Michael Brown, Molly Shutt, Brittany McDonough, Rahul Jadia Ph.D., Omega Funds, Sujit Tatke, Lisa Donnelly, Masha Dumanis, Scott Sigman MD, Gerald Hodgkinson, PhD, Justin Barbas, TOM GAMACHE, Mira Sahney, Lisa Donnelly, Rajit Kamal, Ibraheem Badejo, PhD, MLS, Sectoral Asset Management, Endeavour Vision, Amzak Capital Management, NFL Players Association #Medtech #Startups #KeepInnovating

Wishing Brian Hess and the RevBio, Inc. team the best as they gear up for the LSI USA 24' conference next week! It was a pleasure to host Brian on The MedTech Impact Podcast, where he shared their journey and talked about the orthopedic and dental problems they're looking to solve. A standout moment was learning about their inspiration from marine animals in creating Tetranite, a synthetic bone adhesive. Catch the entire episode on your favorite podcast platform or by clicking the link in the comments section! - 🚀 #medicaldevice #medicaldevices #orthopedics #orthopedicsurgery #dental #dentistry